Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

10.0%

2 terminated/withdrawn out of 20 trials

Success Rate

88.2%

+1.7% vs industry average

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

27%

4 of 15 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

N/A

7(63.6%)

Phase 3

2(18.2%)

Phase 2

1(9.1%)

Phase 1

1(9.1%)

11Total

N/A(7)

Phase 3(2)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials

NCT07195864Recruiting

Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the "Medicines in Special Situations" (Medicamentos en Situaciones Especiales) Program in Spain.

Role: lead

NCT05777798Completed

Clinical Investigation on the Use of Ophthalmic Solution Based on Sodium Hyaluronate in Treatment of Eye Discomfort

Role: lead

NCT06250855Completed

Observational Prospective Clinical Investigation on Monofocal Toric Intraocular Lens

Role: lead

NCT06641882Completed

Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/ml Polihexanide

Role: lead

NCT06093880Active Not Recruiting

Observational, Prospective Clinical Investigation on Mini 4 Ready Intraocular Lens

Role: lead

NCT05778942Completed

Investigation of Preservative-Free Ophthalmic Solution in Ocular Dryness

Role: lead

NCT03274895Phase 3Completed

Polihexanide (PHMB) Eye Drops in Patients Affected by Acanthamoeba Keratitis

Role: lead

NCT03861351Not ApplicableCompleted

Non-comparative Trial Following Participants Implanted Bilaterally With Mini WELL Toric Ready Intraocular Lens for 6 Months After the Second Eye Implant (FUSION)

Role: lead

NCT03803748Not ApplicableCompleted

A Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi®

Role: lead

NCT04645446Phase 2Completed

Safety and Efficacy of Two Different Concentrations (0.5% and 1%) of Progesterone Topical Gel Compared to Placebo in Patients Diagnosed With Moderate to Severe Dry Eye Syndrome

Role: lead

NCT03803722Not ApplicableTerminated

To Demonstrate the Non-inferiority of Eyestil Protection® Compared to Vismed® in Terms of Clinical Performance

Role: lead

NCT02740010Completed

The Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus

Role: lead

NCT04801992Completed

Trial Following Subjects Bilaterally Implanted With Mini Well Ready For 2 Years After the Second Eye Implant

Role: lead

NCT03060954Not ApplicableTerminated

Non-Inferiority Study Comparing MINI WELL READY® and FineVision® in Patients With Cataract Surgery

Role: lead

NCT02838004Not ApplicableCompleted

Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens

Role: lead

NCT02973880Phase 3Completed

Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction

Role: lead

NCT03726606Not ApplicableUnknown

A Comparison of the Visual Performance of Trifocal Versus Extended Depth of Focus Intraocular Lenses

Role: collaborator

NCT02506257Phase 1Completed

Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects

Role: lead

NCT02124603Completed

Microbiological Evaluation of the Ocular Flora Before Cataract Surgery

Role: lead

NCT01959854Not ApplicableCompleted

Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye

Role: lead

All 20 trials loaded